Osorio J, Rodríguez-Santiago J, Muñoz E, Camps J, Veloso E, Marco C
Service of General and Digestive Surgery, Hospital Mutua de Terrassa, Universitat de Barcelona, Terrassa, Spain.
Clin Transl Oncol. 2008 May;10(5):294-7. doi: 10.1007/s12094-008-0200-2.
Most gastric adenocarcinomas in western countries are locally advanced, and these tumours are often associated with metastatic spread at the time of diagnosis. It is controversial whether palliative surgery can improve symptom control in gastric cancer patients with peritoneal carcinomatosis.
To determine the need of palliative procedures and survival in patients affected by gastric cancer with peritoneal carcinomatosis managed without resection. Methods and materials After standard preoperative staging, 160 patients were diagnosed with resectable gastric adenocarcinoma. Laparoscopy was performed in 107 patients (66.9%), finding peritoneal spread in 22 of them (21%). Seventeen of these patients were not submitted to any additional surgical procedure. Data regarding postoperative morbidity and mortality, need of endoscopic, percutaneous or surgical procedures to palliate symptoms, hospital stay and survival were collected. The same data were collected for the 6 non-resected patients who were diagnosed with carcinomatosis by laparotomy.
In the "laparoscopy alone" group, there were 2 minor complications and no postoperative mortality. Mean postoperative stay was 6 days. Eight patients had to be readmitted to hospital for symptoms derived from tumour progression, and 10 palliative endoscopic procedures were performed. Surgical interventions were not needed in any case. Mean survival was 11.5 months. Patients submitted only to laparotomy presented higher morbidity and mortality rates, with a longer postoperative stay and survival of less than 5 months.
Laparoscopic staging of gastric cancer can help to avoid unnecessary laparotomies. In patients with peritoneal carcinomatosis diagnosed by laparoscopy, nonsurgical treatment has low morbidity and mortality and permits good symptom relief with no shortening of survival.
西方国家的大多数胃腺癌为局部晚期,这些肿瘤在诊断时往往伴有转移扩散。对于伴有腹膜种植转移的胃癌患者,姑息性手术是否能改善症状控制存在争议。
确定对未行切除术治疗的伴有腹膜种植转移的胃癌患者进行姑息性手术的必要性及生存情况。方法与材料:在进行标准的术前分期后,160例患者被诊断为可切除的胃腺癌。107例患者(66.9%)接受了腹腔镜检查,其中22例(21%)发现有腹膜转移。这些患者中有17例未接受任何额外的手术。收集了有关术后发病率和死亡率、缓解症状所需的内镜、经皮或手术操作、住院时间和生存情况的数据。对通过剖腹术诊断为腹膜种植转移的6例未行切除术的患者也收集了相同的数据。
在“单纯腹腔镜检查”组中,有2例轻微并发症,无术后死亡。术后平均住院时间为6天。8例患者因肿瘤进展导致的症状需再次入院,且进行了10次姑息性内镜操作。在任何情况下均无需手术干预。平均生存期为11.5个月。仅接受剖腹术的患者发病率和死亡率较高,术后住院时间更长,生存期不到5个月。
胃癌的腹腔镜分期有助于避免不必要的剖腹术。对于通过腹腔镜诊断为腹膜种植转移的患者,非手术治疗发病率和死亡率低,能有效缓解症状且不缩短生存期。